|
| 36621880 | Returning integrated genomic risk and clinical recommendations: The eMERGE study. | Genet Med | 2023 |
| 37579253 | Germline <i>EGFR</i> Mutations and Familial Lung Cancer. | J Clin Oncol | 2023 |
| 37015332 | Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2023 |
| 34665896 | Do research participants share genomic screening results with family members? | J Genet Couns | 2022 |
| 35446370 | Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases. | JAMA Oncol | 2022 |
| 36422086 | Outcomes of Returning Medically Actionable Genomic Results in Pediatric Research. | J Pers Med | 2022 |
| 36048450 | Hereditary Cancer Syndromes-A Broader Clinical Spectrum Than Previously Understood?-Reply. | JAMA Oncol | 2022 |
| 35943490 | Pathogenic variants in arteriopathy genes detected in a targeted sequencing study: Penetrance and 1-year outcomes after return of results. | Genet Med | 2022 |
| 35130500 | Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2022 |
| 35216901 | The reckoning: The return of genomic results to 1444 participants across the eMERGE3 Network. | Genet Med | 2022 |
| 35341654 | Impact of returning unsolicited genomic results to nongenetic health care providers in the eMERGE III Network. | Genet Med | 2022 |
| 33389527 | Increased ease of access to genetic counseling for low-income women with breast cancer using a point of care screening tool. | J Community Genet | 2021 |
| 34377931 | Penetrance of Breast Cancer Susceptibility Genes From the eMERGE III Network. | JNCI Cancer Spectr | 2021 |
| 34666312 | NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021. | J Natl Compr Canc Netw | 2021 |
| 34390291 | Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer Center. | Oncologist | 2021 |
| 34347061 | Generalizability of Polygenic Risk Scores for Breast Cancer Among Women With European, African, and Latinx Ancestry. | JAMA Netw Open | 2021 |
| 34257418 | Neptune: an environment for the delivery of genomic medicine. | Genet Med | 2021 |
| 33420026 | Lossless integration of multiple electronic health records for identifying pleiotropy using summary statistics. | Nat Commun | 2021 |
| 31553110 | Patients' willingness to reconsider cancer genetic testing after initially declining: Mention it again. | J Genet Couns | 2020 |
| 31967672 | Breast cancer screening implications of risk modeling among female relatives of ATM and CHEK2 carriers. | Cancer | 2020 |
| 32634774 | A Web-Based Tool to Automate Portions of Pretest Genetic Counseling for Inherited Cancer. | J Natl Compr Canc Netw | 2020 |
| 32413979 | Understanding the Return of Genomic Sequencing Results Process: Content Review of Participant Summary Letters in the eMERGE Research Network. | J Pers Med | 2020 |
| 32329193 | Patient perspectives on variant reclassification after cancer susceptibility testing. | Mol Genet Genomic Med | 2020 |
| 32349224 | Returning Results in the Genomic Era: Initial Experiences of the eMERGE Network. | J Pers Med | 2020 |
| 30729418 | Implementation of a Systematic Tumor Screening Program for Lynch Syndrome in an Integrated Health Care Setting. | Fam Cancer | 2019 |
| 31890059 | Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods study. | Hered Cancer Clin Pract | 2019 |
| 31737042 | Genomic Information for Clinicians in the Electronic Health Record: Lessons Learned From the Clinical Genome Resource Project and the Electronic Medical Records and Genomics Network. | Front Genet | 2019 |
| 29904163 | Physicians' perspectives on receiving unsolicited genomic results. | Genet Med | 2019 |
| 29875428 | The impact of variant classification on the clinical management of hereditary cancer syndromes. | Genet Med | 2019 |
| 29301385 | Ethical Considerations Related to Return of Results from Genomic Medicine Projects: The eMERGE Network (Phase III) Experience. | J Pers Med | 2018 |
| 30055521 | Subsequent breast and high grade serous carcinomas after risk-reducing salpingo-oophorectomy in BRCA mutation carriers and patients with history of breast cancer. | Ann Diagn Pathol | 2018 |
| 29760830 | Patient and provider perspectives on adherence to and care coordination of lynch syndrome surveillance recommendations: findings from qualitative interviews. | Hered Cancer Clin Pract | 2018 |
| 28040716 | NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. | J Natl Compr Canc Netw | 2017 |
| 28176204 | Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives. | Fam Cancer | 2017 |
| 28973705 | Identification and Management of <i>TP53</i> Gene Carriers Detected Through Multigene Panel Testing. | South Med J | 2017 |
| 25880440 | Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators. | Genet Med | 2016 |
| 27767224 | Ethical, Legal, and Social Implications of Personalized Genomic Medicine Research: Current Literature and Suggestions for the Future. | Bioethics | 2016 |
| 26850485 | Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. | J Natl Compr Canc Netw | 2016 |
| 25394175 | A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. | Genet Med | 2015 |
| 26036338 | Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers. | Cancer | 2015 |
| 24838973 | Inactivating mutation in the prostaglandin transporter gene, SLCO2A1, associated with familial digital clubbing, colon neoplasia, and NSAID resistance. | Cancer Prev Res (Phila) | 2014 |
| 25190699 | Gene panel testing for inherited cancer risk. | J Natl Compr Canc Netw | 2014 |
| 25190698 | Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. | J Natl Compr Canc Netw | 2014 |
| 22241094 | IRB perspectives on the return of individual results from genomic research. | Genet Med | 2012 |
| 22241102 | Genetics researchers' and IRB professionals' attitudes toward genetic research review: a comparative analysis. | Genet Med | 2012 |
| 21487211 | Attitudes toward genetic research review: results from a survey of human genetics researchers. | Public Health Genomics | 2011 |
| 19797908 | Program update and novel use of the DESPAIR program to design a genome-wide linkage study using relative pairs. | Hum Hered | 2010 |
| 20551049 | Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22. | Cancer Res | 2010 |
| 20235866 | Attitudes toward genetic research review: results from a national survey of professionals involved in human subjects protection. | J Empir Res Hum Res Ethics | 2010 |
| 19509225 | Infrequent detection of germline allele-specific expression of TGFBR1 in lymphoblasts and tissues of colon cancer patients. | Cancer Res | 2009 |